INCY

INCYTE CORP

INCY·45337C102·US·Common Stock·Healthcare - Biotechnology-Activist

INCY (INCYTE CORP) is held by 275 institutional investors as of Q1 2026. Largest holders: BAKER BROS. ADVISORS LP ($2.9B), BlackRock, Inc. ($1.8B), DODGE & COX ($1.2B). Net institutional sentiment: Mixed.

275
Holders
(25 Elite)
$17.3B
Total Value
56% (279)
Consensus
157 buying - 122 selling
13F: Insider & Congress:
INCY

Smart Money Verdict

View all
Held by 275 funds
25 elite

Who's Trading

InsiderMAMayes Patrick ASell $274KAug 5, 2026
InsiderMAMayes Patrick ASell $729KAug 3, 2026
InsiderMAMayes Patrick ASell $1.8MJul 31, 2026
InsiderMAMayes Patrick ASell $637KJul 31, 2026
InsiderMAMayes Patrick ASell $261KJul 31, 2026
InsiderMAMayes Patrick ASell $737KJul 31, 2026
InsiderMAMayes Patrick ASell $561KJul 31, 2026
ActivistDodge & CoxDodge & Cox6.2%May 14, 2026
ActivistBaker Bros. Advisors LPBaker Bros. Advisors LP15.4%May 11, 2026
CongressRob BresnahanRob BresnahanSale $1,001 - $15,000May 15, 2025

Top Holders

Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
30.7M$2.9B16.6%+41.78%
62
Increased
19M(+3.5%)$1.8B0.0%+72.84%
33
Decreased
12.3M(-7.6%)$1.2B0.6%+55.95%
0
New
10.9M$1B0.0%+22.93%
44
Decreased
9.6M(-0.2%)$907.4M0.0%+92.59%
0
New
7.8M$730.3M0.0%+22.93%
44
Decreased
5.8M(-13.6%)$536.1M0.2%+87.90%
0
Decreased
4.7M(-5.8%)$441.1M0.0%+67.06%
0
Increased
3.9M(+11.4%)$364.3M0.1%+55.99%
35
Decreased
3.7M(-8.2%)$343.7M0.5%+49.05%
0
Increased
3.3M(+341.7%)$307.4M0.1%+22.94%
50
Increased
2.9M(+7.0%)$268.3M0.0%+84.42%
33
Decreased
2.8M(-8.5%)$266.4M0.1%+72.08%
0
Increased
2.5M(+1.4%)$236.7M0.3%+75.61%
37
Increased
2.4M(+83.2%)$221.3M0.0%+44.37%
47
Decreased
2.1M(-6.3%)$201.9M0.8%+42.35%
0
Increased
2M(+10.5%)$185.9M0.0%+60.92%
34
Increased
1.8M(+5.0%)$174.1M0.0%+45.22%
32
Increased
1.7M(+19.9%)$164M0.1%+62.19%
43
Decreased
1.7M(-0.2%)$162.7M0.0%+74.58%
0

Showing 1-20 of 289

1 / 15
INCYINCYINCYTE CORP

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used